National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

Past Highlights
   
 
Results: 1 -4 of 4         results per page
View Search Criteria | Help With Results
           

1.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase IV


Supportive care


Active


21 and over


NCI, Other


04-08-09-04
NCT00245518

First Published: 10/1/2008  

2.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III, Phase II


Biomarker/Laboratory analysis, Treatment


Active


40 to 75


NCI


UIC-2006-0706
2006-0706, NCT00765479

Last Modified: 1/13/2009     First Published: 7/14/2006  

3.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Supportive care


Active


21 and over


NCI


CCCWFU-97405
CCCWFU 97405, CCCWFU-BG05-529, NCT00354432


4.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Prevention


Active


30 to 40


Other


02-422
Army's HSRRB log no. A-10926, UTMB GCRC 533, DAMD17-01-1-0417, NIH NCRR GCRC M01 RR00073, NCT00204477

   
   

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov